PREPRINT (not peer-reviewed). Copper coordination changed zidovudine's response pattern more than its average activity in a one-dose cancer-cell screen. Manning and Purvis compared zidovudine (AZT) with a Cu(II)-AZT complex at 10 μM across the NCI-60 panel, using growth relative to untreated controls. AZT's mean growth was 98.27%; the complex was similar at 96.05%, but melanoma average growth fell from about 98.9% to 69.4%. In MDA-MB-435 melanoma cells, CuAZT gave −61.63% growth, reported as net cell death, whereas AZT gave 94.35% growth. This is a single-concentration screen, not a dose-response, therapeutic, or mechanism study; the proposed biological explanations remain untested. Find the paper on ChemRxiv by searching the exact title: Effect of Cu(II) Complexation on the Anticancer Activity of Zidovudine in the NCI-60 Human Tumor Cell Line Screen.
10:40:17 PM · Nov 22, 2026
Sign in to reply and join the conversation.
